SARS-CoV-2 mRNA Vaccine-Induced Cellular and Humoral Immunity in Hemodialysis Patients

SARS-CoV-2 mRNA Vaccine-Induced Cellular and Humoral Immunity in Hemodialysis Patients

Background/Aims: Chronic kidney disease CKD patients on intermittent hemodialysis IHD are exposed to SARS-CoV-2 infection and carry a risk of developing severe symptoms. The aim of this study was to evaluate the humoral and cellular immunity induced by two doses of mRNA vaccines, the Pfizer-BioNTech...

Full description

Bibliographic Details
Main Authors: Ewa Kwiatkowska, Krzysztof Safranow, Iwona Wojciechowska-Koszko, Paulina Roszkowska, Violetta Dziedziejko, Marek Myślak, Jacek Różański, Kazimierz Ciechanowski, Tomasz Stompór, Jarosław Przybyciński, Piotr Wiśniewski, Norbert Kwella, Sebastian Kwiatkowski, Tomasz Prystacki, Wojciech Marcinkowski, Leszek Domański
Format: Article
Language:English
Published: MDPI AG 2022-03-01
Series:Biomedicines
Subjects:
SARS-CoV-2
mRNA vaccination
humoral immunity
cellular immunity
Online Access:https://www.mdpi.com/2227-9059/10/3/636

Internet

https://www.mdpi.com/2227-9059/10/3/636

Similar Items